Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Pharoah P, Antoniou A, Berchuck A, Chenevix-Trench G, Gayther S, Goode E, Milne R, Sellers T, Tyrer J. Association between KRAS rs61764370 and triple-negative breast cancer--a false positive? Lancet Oncol 2011;12:723-4; author reply 724. [PMID: 21807336 DOI: 10.1016/s1470-2045(11)70156-5] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]

For:	Pharoah P, Antoniou A, Berchuck A, Chenevix-Trench G, Gayther S, Goode E, Milne R, Sellers T, Tyrer J. Association between KRAS rs61764370 and triple-negative breast cancer--a false positive? Lancet Oncol 2011;12:723-4; author reply 724. [PMID: 21807336 DOI: 10.1016/s1470-2045(11)70156-5] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]

Number

Cited by Other Article(s)

Hollestelle A, van der Baan FH, Berchuck A, Johnatty SE, Aben KK, Agnarsson BA, Aittomäki K, Alducci E, Andrulis IL, Anton-Culver H, Antonenkova NN, Antoniou AC, Apicella C, Arndt V, Arnold N, Arun BK, Arver B, Ashworth A, Baglietto L, Balleine R, Bandera EV, Barrowdale D, Bean YT, Beckmann L, Beckmann MW, Benitez J, Berger A, Berger R, Beuselinck B, Bisogna M, Bjorge L, Blomqvist C, Bogdanova NV, Bojesen A, Bojesen SE, Bolla MK, Bonanni B, Brand JS, Brauch H, Brenner H, Brinton L, Brooks-Wilson A, Bruinsma F, Brunet J, Brüning T, Budzilowska A, Bunker CH, Burwinkel B, Butzow R, Buys SS, Caligo MA, Campbell I, Carter J, Chang-Claude J, Chanock SJ, Claes KBM, Collée JM, Cook LS, Couch FJ, Cox A, Cramer D, Cross SS, Cunningham JM, Cybulski C, Czene K, Damiola F, Dansonka-Mieszkowska A, Darabi H, de la Hoya M, deFazio A, Dennis J, Devilee P, Dicks EM, Diez O, Doherty JA, Domchek SM, Dorfling CM, Dörk T, Silva IDS, du Bois A, Dumont M, Dunning AM, Duran M, Easton DF, Eccles D, Edwards RP, Ehrencrona H, Ejlertsen B, Ekici AB, Ellis SD, Engel C, Eriksson M, Fasching PA, Feliubadalo L, Figueroa J, Flesch-Janys D, Fletcher O, Fontaine A, Fortuzzi S, Fostira F, Fridley BL, Friebel T, Friedman E, Friel G, Frost D, Garber J, García-Closas M, Gayther SA, Gentry-Maharaj A, Gerdes AM, Giles GG, Glasspool R, Glendon G, Godwin AK, Goodman MT, Gore M, Greene MH, Grip M, Gronwald J, Gschwantler Kaulich D, Guénel P, Guzman SR, Haeberle L, Haiman CA, Hall P, Halverson SL, Hamann U, Hansen TVO, Harter P, Hartikainen JM, Healey S, Hein A, Heitz F, Henderson BE, Herzog J, T Hildebrandt MA, Høgdall CK, Høgdall E, Hogervorst FBL, Hopper JL, Humphreys K, Huzarski T, Imyanitov EN, Isaacs C, Jakubowska A, Janavicius R, Jaworska K, Jensen A, Jensen UB, Johnson N, Jukkola-Vuorinen A, Kabisch M, Karlan BY, Kataja V, Kauff N, Kelemen LE, Kerin MJ, Kiemeney LA, Kjaer SK, Knight JA, Knol-Bout JP, Konstantopoulou I, Kosma VM, Krakstad C, Kristensen V, Kuchenbaecker KB, Kupryjanczyk J, Laitman Y, Lambrechts D, Lambrechts S, Larson MC, Lasa A, Laurent-Puig P, Lazaro C, Le ND, Le Marchand L, Leminen A, Lester J, Levine DA, Li J, Liang D, Lindblom A, Lindor N, Lissowska J, Long J, Lu KH, Lubinski J, Lundvall L, Lurie G, Mai PL, Mannermaa A, Margolin S, Mariette F, Marme F, Martens JWM, Massuger LFAG, Maugard C, Mazoyer S, McGuffog L, McGuire V, McLean C, McNeish I, Meindl A, Menegaux F, Menéndez P, Menkiszak J, Menon U, Mensenkamp AR, Miller N, Milne RL, Modugno F, Montagna M, Moysich KB, Müller H, Mulligan AM, Muranen TA, Narod SA, Nathanson KL, Ness RB, Neuhausen SL, Nevanlinna H, Neven P, Nielsen FC, Nielsen SF, Nordestgaard BG, Nussbaum RL, Odunsi K, Offit K, Olah E, Olopade OI, Olson JE, Olson SH, Oosterwijk JC, Orlow I, Orr N, Orsulic S, Osorio A, Ottini L, Paul J, Pearce CL, Pedersen IS, Peissel B, Pejovic T, Pelttari LM, Perkins J, Permuth-Wey J, Peterlongo P, Peto J, Phelan CM, Phillips KA, Piedmonte M, Pike MC, Platte R, Plisiecka-Halasa J, Poole EM, Poppe B, Pylkäs K, Radice P, Ramus SJ, Rebbeck TR, Reed MWR, Rennert G, Risch HA, Robson M, Rodriguez GC, Romero A, Rossing MA, Rothstein JH, Rudolph A, Runnebaum I, Salani R, Salvesen HB, Sawyer EJ, Schildkraut JM, Schmidt MK, Schmutzler RK, Schneeweiss A, Schoemaker MJ, Schrauder MG, Schumacher F, Schwaab I, Scuvera G, Sellers TA, Severi G, Seynaeve CM, Shah M, Shrubsole M, Siddiqui N, Sieh W, Simard J, Singer CF, Sinilnikova OM, Smeets D, Sohn C, Soller M, Song H, Soucy P, Southey MC, Stegmaier C, Stoppa-Lyonnet D, Sucheston L, Swerdlow A, Tangen IL, Tea MK, Teixeira MR, Terry KL, Terry MB, Thomassen M, Thompson PJ, Tihomirova L, Tischkowitz M, Toland AE, Tollenaar RAEM, Tomlinson I, Torres D, Truong T, Tsimiklis H, Tung N, Tworoger SS, Tyrer JP, Vachon CM, Van 't Veer LJ, van Altena AM, Van Asperen CJ, van den Berg D, van den Ouweland AMW, van Doorn HC, Van Nieuwenhuysen E, van Rensburg EJ, Vergote I, Verhoef S, Vierkant RA, Vijai J, Vitonis AF, von Wachenfeldt A, Walsh C, Wang Q, Wang-Gohrke S, Wappenschmidt B, Weischer M, Weitzel JN, Weltens C, Wentzensen N, Whittemore AS, Wilkens LR, Winqvist R, Wu AH, Wu X, Yang HP, Zaffaroni D, Pilar Zamora M, Zheng W, Ziogas A, Chenevix-Trench G, Pharoah PDP, Rookus MA, Hooning MJ, Goode EL. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecol Oncol 2016;141:386-401. [PMID: 25940428 PMCID: PMC4630206 DOI: 10.1016/j.ygyno.2015.04.034] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2015] [Accepted: 04/19/2015] [Indexed: 12/24/2022]

Affiliation(s)

Antoinette Hollestelle Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
Frederieke H van der Baan Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands
Andrew Berchuck Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA.
Sharon E Johnatty Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia
Katja K Aben Comprehensive Cancer Center The Netherlands, Utrecht, The Netherlands; Department for Health Evidence, Radboud University Medical Centre, Nijmegen, The Netherlands
Bjarni A Agnarsson Landspitali University Hospital, Reykjavik, Iceland; University of Iceland, School of Medicine, Reykjavik, Iceland
Kristiina Aittomäki Department of Clinical Genetics, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland
Elisa Alducci Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy
Irene L Andrulis Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada; Ontario Cancer Genetics Network, Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada
Hoda Anton-Culver Department of Epidemiology, University of California Irvine, Irvine, CA, USA
Natalia N Antonenkova N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus
Antonis C Antoniou Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Carmel Apicella Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia
Volker Arndt Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany
Norbert Arnold Department of Gynecology and Obstetrics, University Hospital of Schleswig-Holstein, University Kiel, Kiel, Germany
Banu K Arun Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Clinical Cancer Genetics, University of Texas MD Anderson Cancer Center, Houston, TX, USA
Brita Arver Department of Oncology, Karolinska University Hospital, Stockholm, Sweden
Alan Ashworth Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, UK
Laura Baglietto Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, VIC, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia
Rosemary Balleine Western Sydney and Nepean Blue Mountains Local Health Districts, Westmead Millennium Institute for Medical Research, University of Sydney, Sydney, Australia
Elisa V Bandera Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School, New Brunswick, NJ, USA
Daniel Barrowdale Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Yukie T Bean Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR, USA; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA
Lars Beckmann Institute for Quality and Efficiency in Health Care (IQWiG), Cologne, Germany
Matthias W Beckmann University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany
Javier Benitez Centro Nacional de Genotipación, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany; Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain
Andreas Berger Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
Raanan Berger Sheba Medical Center, Tel Aviv, Israel
Benoit Beuselinck Multidisciplinary Breast Center, University Hospital Leuven, University of Leuven, Belgium
Maria Bisogna Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Line Bjorge Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway; Department of Clinical Science, University of Bergen, Bergen, Norway
Carl Blomqvist Department of Oncology, University of Helsinki, Helsinki University Central Hospital, Helsinki, Finland
Natalia V Bogdanova Department of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany; Department of Radiation Oncology, Hannover Medical School, Hannover, Germany
Anders Bojesen Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark
Stig E Bojesen Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark; Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark
Manjeet K Bolla Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Bernardo Bonanni Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia (IEO), Milan, Italy
Judith S Brand Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
Hiltrud Brauch Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany; University of Tübingen, Tübingen, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; Cancer Research Center (DKFZ), Heidelberg, Germany
Hermann Brenner Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany
Louise Brinton Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
Angela Brooks-Wilson Genome Sciences Centre, BC Cancer Agency, Vancouver, BC, Canada; Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, BC, Canada
Fiona Bruinsma Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, VIC, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia
Joan Brunet Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI-Catalan Institute of Oncology, Girona, Spain
Thomas Brüning Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany
Agnieszka Budzilowska Department of Pathology and Laboratory Diagnostics, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland
Clareann H Bunker Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA
Barbara Burwinkel Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany; Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany
Ralf Butzow Department of Pathology, Helsinki University Central Hospital, Helsinki, Finland; Department of Obstetrics and Gynecology, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland
Saundra S Buys Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA
Maria A Caligo Section of Genetic Oncology, Department of Laboratory Medicine, University Hospital of Pisa, University of Pisa, Pisa, Italy
Ian Campbell Cancer Genetics Laboratory, Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Australia; Department of Pathology, University of Melbourne, Melbourne, VIC, Australia
Jonathan Carter Gynaecological Oncology, The Chris O'Brien Lifehouse and The University of Sydney, Sydney, Australia
Jenny Chang-Claude Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
Stephen J Chanock Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
Kathleen B M Claes Center for Medical Genetics, Ghent University, Ghent, Belgium
J Margriet Collée Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands
Linda S Cook Division of Epidemiology and Biostatistics, University of New Mexico, Albuquerque, NM, USA
Fergus J Couch Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA; Department of Laboratory Medicine and Pathology, Division of Experimental Pathology, Mayo Clinic, Rochester, MN, USA
Angela Cox Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Sheffield, UK
Daniel Cramer Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, MA, USA; Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA; Harvard Medical School, Boston, MA, USA
Simon S Cross Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK
Julie M Cunningham Department of Laboratory Medicine and Pathology, Division of Experimental Pathology, Mayo Clinic, Rochester, MN, USA
Cezary Cybulski International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical Academy, Szczecin, Poland
Kamila Czene Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
Francesca Damiola INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France
Agnieszka Dansonka-Mieszkowska Department of Pathology and Laboratory Diagnostics, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland
Hatef Darabi Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
Miguel de la Hoya Molecular Oncology Laboratory, Hospital Clinico San Carlos, Madrid, Spain
Anna deFazio Center for Cancer Research, University of Sydney at Westmead Millennium Institute, Sydney, Australia; Department of Gynaecological Oncology, Westmead Hospital, Sydney, Australia
Joseph Dennis Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Peter Devilee Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands
Ed M Dicks Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK
Orland Diez Oncogenetics Laboratory, University Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
Jennifer A Doherty Section of Biostatistics and Epidemiology, The Geisel School of Medicine at Dartmouth, Lebanon, NH, USA
Susan M Domchek Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Basser Research Centre, Abramson Cancer Center, The University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA
Cecilia M Dorfling Department of Genetics, University of Pretoria, Pretoria, South Africa
Thilo Dörk Department of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany
Isabel Dos Santos Silva Non-Communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine, London, UK
Andreas du Bois Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Klinik Wiesbaden, Wiesbaden, Germany; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany
Martine Dumont Centre Hospitalier Universitaire de Québec Research Center, Laval University, Quebec, Canada
Alison M Dunning Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK
Mercedes Duran Institute of Biology and Molecular Genetics, Universidad de Valladolid (IBGM-UVA), Valladolid, Spain
Douglas F Easton Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK
Diana Eccles Faculty of Medicine, University of Southampton, University Hospital Southampton, Southampton, UK
Robert P Edwards Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Gynecologic Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Hans Ehrencrona Department of Clinical Genetics, Lund University, Lund, Sweden
Bent Ejlertsen Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
Arif B Ekici Institute of Human Genetics, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany
Steve D Ellis Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Christoph Engel Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany
Mikael Eriksson Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
Peter A Fasching University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany; David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, University of California at Los Angeles, CA, USA
Lidia Feliubadalo Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain
Jonine Figueroa Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
Dieter Flesch-Janys Department of Cancer Epidemiology/Clinical Cancer Registry, Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg, Germany
Olivia Fletcher Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, UK
Annette Fontaine Clinical Cancer Genetics, City of Hope, Duarte, CA, USA; New Mexico Cancer Center, Albuquerque, NM, USA
Stefano Fortuzzi Fondazione Istituto FIRC di Oncologia Molecolare (IFOM), Milan, Italy; Cogentech Cancer Genetic Test Laboratory, Milan, Italy
Florentia Fostira Molecular Diagnostics Laboratory, Institute of Nuclear & Radiological Sciences & Technology, Energy & Safety, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece
Brooke L Fridley Kansas IDeA Network of Biomedical Research Excellence Bioinformatics Core, The University of Kansas Cancer Center, Kansas City, KS, USA
Tara Friebel University of Pennsylvania, Philadelphia, PA, USA
Eitan Friedman The Susanne Levy Gertner Oncogenetics Unit, Sheba Medical Center, Tel-Hashomer, Israel; Institute of Oncology, Sheba Medical Center, Tel-Hashomer, Israel
Grace Friel Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA
Debra Frost Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Judy Garber Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA
Montserrat García-Closas Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, UK
Simon A Gayther Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
Aleksandra Gentry-Maharaj Gynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, UCL, London, UK
Anne-Marie Gerdes Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
Graham G Giles Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, VIC, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia
Rosalind Glasspool Cancer Research UK Clinical Trials Unit, The Beatson West of Scotland Cancer Centre, Glasgow, UK
Gord Glendon Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada
Andrew K Godwin Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA
Marc T Goodman Samuel Oschin Comprehensive Cancer Institute, Cedars Sinai Medical Center, Los Angeles, CA, USA
Martin Gore Gynecological Oncology Unit, The Royal Marsden Hospital, London, UK
Mark H Greene Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA
Mervi Grip Department of Surgery, Oulu University Hospital, University of Oulu, Oulu, Finland
Jacek Gronwald Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland
Daphne Gschwantler Kaulich Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
Pascal Guénel INSERM U1018, CESP (Center for Research in Epidemiology and Population Health), Environmental Epidemiology of Cancer, Villejuif, France; University Paris-Sud, UMRS 1018, Villejuif, France
Starr R Guzman Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA
Lothar Haeberle University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany
Christopher A Haiman Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
Per Hall Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
Sandra L Halverson Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA
Ute Hamann Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany
Thomas V O Hansen Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
Philipp Harter Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Klinik Wiesbaden, Wiesbaden, Germany; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany
Jaana M Hartikainen Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, Biocenter Kuopio, Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland
Sue Healey Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia
Alexander Hein University Hospital Erlangen, Department of Gynecology and Obstetrics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center, Erlangen, Germany
Florian Heitz Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Klinik Wiesbaden, Wiesbaden, Germany; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany
Brian E Henderson Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
Josef Herzog Clinical Cancer Genetics, City of Hope, Duarte, CA, USA
Michelle A T Hildebrandt Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Claus K Høgdall Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Estrid Høgdall Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark; Molecular Unit, Department of Pathology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark
Frans B L Hogervorst Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
John L Hopper Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia
Keith Humphreys Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
Tomasz Huzarski Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland
Evgeny N Imyanitov N.N. Petrov Institute of Oncology, St. Petersburg, Russia
Claudine Isaacs Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA
Anna Jakubowska Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland
Ramunas Janavicius Vilnius University Hospital Santariskiu Clinics, Hematology, Oncology and Transfusion Medicine Center, Department of Molecular and Regenerative Medicine, State Research Centre Institute for Innovative Medicine, Vilnius, Lithuania
Katarzyna Jaworska Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland; Postgraduate School of Molecular Medicine, Warsaw Medical University, Warsaw, Poland
Allan Jensen Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark
Uffe Birk Jensen Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark
Nichola Johnson Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, UK
Arja Jukkola-Vuorinen Department of Oncology, Oulu University Hospital, University of Oulu, Oulu, Finland
Maria Kabisch Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany
Beth Y Karlan Women's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA
Vesa Kataja School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, Biocenter Kuopio, Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland; Jyväskylä Central Hospital, Jyväskylä, Finland
Noah Kauff Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Linda E Kelemen Department of Population Health Research, Alberta Health Services-Cancer Care, Calgary, Alberta, Canada; Department of Medical Genetics, University of Calgary, Calgary, Alberta, Canada; Department of Oncology, University of Calgary, Calgary, Alberta, Canada
Michael J Kerin School of Medicine, National University of Ireland, Galway, Ireland
Lambertus A Kiemeney Department for Health Evidence, Radboud University Medical Centre, Nijmegen, The Netherlands; Department of Urology, Radboud University Medical Centre, Nijmegen, The Netherlands
Susanne K Kjaer Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark
Julia A Knight Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada; Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada
Jacoba P Knol-Bout Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands
Irene Konstantopoulou Molecular Diagnostics Laboratory, Institute of Nuclear & Radiological Sciences & Technology, Energy & Safety, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece
Veli-Matti Kosma Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, Biocenter Kuopio, Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland
Camilla Krakstad Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway; Department of Clinical Science, University of Bergen, Bergen, Norway
Vessela Kristensen Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo, Norway; Faculty of Medicine (Faculty Division Ahus), Universitetet i Oslo, Norway
Karoline B Kuchenbaecker Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Jolanta Kupryjanczyk Department of Pathology and Laboratory Diagnostics, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland
Yael Laitman The Susanne Levy Gertner Oncogenetics Unit, Sheba Medical Center, Tel-Hashomer, Israel; Institute of Oncology, Sheba Medical Center, Tel-Hashomer, Israel
Diether Lambrechts Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Belgium; Vesalius Research Center (VRC), VIB, Leuven, Belgium
Sandrina Lambrechts Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven, Belgium; Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium
Melissa C Larson Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA
Adriana Lasa Genetic and Molecular Epidemiology Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain
Pierre Laurent-Puig Université Paris Sorbonne Cité, UMR-S775 Inserm, Paris, France
Conxi Lazaro Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain
Nhu D Le Cancer Control Research, BC Cancer Agency, Vancouver, BC, Canada
Loic Le Marchand Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA
Arto Leminen Department of Obstetrics and Gynecology, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland
Jenny Lester Women's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA
Douglas A Levine Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Jingmei Li Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
Dong Liang College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX, USA
Annika Lindblom Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
Noralane Lindor Center for Individualized Medicine, Mayo Clinic, Scottsdale, AZ, USA
Jolanta Lissowska Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center & Institute of Oncology, Warsaw, Poland
Jirong Long Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA
Karen H Lu Department of Gynecologic Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
Jan Lubinski Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland
Lene Lundvall Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Galina Lurie Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA
Phuong L Mai Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA
Arto Mannermaa Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, Biocenter Kuopio, Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland
Sara Margolin Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden
Frederique Mariette Fondazione Istituto FIRC di Oncologia Molecolare (IFOM), Milan, Italy; Cogentech Cancer Genetic Test Laboratory, Milan, Italy
Frederik Marme Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany
John W M Martens Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
Leon F A G Massuger Department of Gynecology, Radboud University Medical Centre, Nijmegen, The Netherlands
Christine Maugard Laboratoire de Diagnostic Génétique et Service d'Onco-hématologie, Hopitaux Universitaire de Strasbourg, CHRU Nouvel Hôpital Civil, Strasbourg, France
Sylvie Mazoyer INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France
Lesley McGuffog Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Valerie McGuire Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA, USA
Catriona McLean Anatomical Pathology, The Alfred Hospital, Melbourne, Australia
Iain McNeish Institute of Cancer Sciences, University of Glasgow, Wolfson Wohl Cancer Research Centre, Beatson Institute for Cancer Research, Glasgow, UK
Alfons Meindl Department of Gynecology and Obstetrics, Division of Tumor Genetics, Klinikum rechts der Isar, Technical University Munich, Munich, Germany
Florence Menegaux INSERM U1018, CESP (Center for Research in Epidemiology and Population Health), Environmental Epidemiology of Cancer, Villejuif, France; University Paris-Sud, UMRS 1018, Villejuif, France
Primitiva Menéndez Servicio de Anatomía Patológica, Hospital Monte Naranco, Oviedo, Spain
Janusz Menkiszak Department of Surgical Gynecology and Gynecological Oncology of Adults and Adolescents, Pomeranian Medical University, Szczecin, Poland
Usha Menon Gynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, UCL, London, UK
Arjen R Mensenkamp Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Nicola Miller School of Medicine, National University of Ireland, Galway, Ireland
Roger L Milne Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, VIC, Australia
Francesmary Modugno Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA; Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Gynecologic Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Women's Cancer Research Program, Magee-Women's Research Institute and University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA
Marco Montagna Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy
Kirsten B Moysich Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA
Heiko Müller Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany
Anna Marie Mulligan Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada; Laboratory Medicine Program, University Health Network, Toronto, ON, Canada
Taru A Muranen Department of Obstetrics and Gynecology, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland
Steven A Narod Women's College Research Institute, University of Toronto, Toronto, ON, Canada
Katherine L Nathanson Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Basser Research Centre, Abramson Cancer Center, The University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA
Roberta B Ness The University of Texas School of Public Health, Houston, TX, USA
Susan L Neuhausen Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA
Heli Nevanlinna Department of Obstetrics and Gynecology, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland
Patrick Neven Multidisciplinary Breast Center, University Hospital Leuven, University of Leuven, Belgium
Finn C Nielsen Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
Sune F Nielsen Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark; Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark
Børge G Nordestgaard Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark; Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark
Robert L Nussbaum Department of Medicine and Institute for Human Genetics, University of California, San Francisco, CA, USA
Kunle Odunsi Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA
Kenneth Offit Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Edith Olah Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary
Olufunmilayo I Olopade Center for Clinical Cancer Genetics and Global Health, University of Chicago Medical Center, Chicago, IL, USA
Janet E Olson Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA
Sara H Olson Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Jan C Oosterwijk University of Groningen, University Medical Center, Department of Genetics, Groningen, The Netherlands
Irene Orlow Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Nick Orr Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, UK
Sandra Orsulic Women's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA
Ana Osorio Human Genetics Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain; Genetic and Molecular Epidemiology Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain
Laura Ottini Department of Molecular Medicine, Sapienza University, Rome, Italy
James Paul Cancer Research UK Clinical Trials Unit, The Beatson West of Scotland Cancer Centre, Glasgow, UK
Celeste L Pearce Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
Inge Sokilde Pedersen Section of Molecular Diagnostics, Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark
Bernard Peissel Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori (INT), Milan, Italy
Tanja Pejovic Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR, USA; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA
Liisa M Pelttari Department of Obstetrics and Gynecology, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland
Jo Perkins Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Jenny Permuth-Wey Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
Paolo Peterlongo Fondazione Istituto FIRC di Oncologia Molecolare (IFOM), Milan, Italy
Julian Peto Non-Communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine, London, UK
Catherine M Phelan Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
Kelly-Anne Phillips Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Australia; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia; Department of Medicine, St Vincent's Hospital, The University of Melbourne, Victoria, Australia
Marion Piedmonte NRG Oncology Statistics and Data Management Center, Buffalo, NY, USA
Malcolm C Pike Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Radka Platte Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Joanna Plisiecka-Halasa Department of Pathology and Laboratory Diagnostics, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland
Elizabeth M Poole Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA; Channing Division of Network Medicine, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA
Bruce Poppe Center for Medical Genetics, Ghent University, Ghent, Belgium
Katri Pylkäs Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Genetics, University of Oulu, Oulu University Hospital, Oulu, Finland; Biocenter Oulu, University of Oulu, Oulu, Finland
Paolo Radice Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori (INT), Milan, Italy
Susan J Ramus Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
Timothy R Rebbeck Basser Research Centre, Abramson Cancer Center, The University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA; Center for Clinical Epidemiology and Biostatistics, The University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
Malcolm W R Reed Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Sheffield, UK
Gad Rennert Clalit National Israeli Cancer Control Center, Haifa, Israel; Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Technion, Haifa, Israel
Harvey A Risch Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, USA
Mark Robson Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Gustavo C Rodriguez NorthShore University Health System, University of Chicago, Evanston, IL, USA
Atocha Romero Molecular Oncology Laboratory, Hospital Clinico San Carlos, Madrid, Spain
Mary Anne Rossing Department of Epidemiology, University of Washington, Seattle, WA, USA; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Joseph H Rothstein Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA, USA
Anja Rudolph Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
Ingo Runnebaum Department of Gynecology, Jena University Hospital, Jena, Germany
Ritu Salani Ohio State University, Columbus, OH, USA
Helga B Salvesen Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway; Department of Clinical Science, University of Bergen, Bergen, Norway
Elinor J Sawyer Division of Cancer Studies, NIHR Comprehensive Biomedical Research Centre, Guy's & St. Thomas' NHS Foundation Trust in partnership with King's College London, London, UK
Joellen M Schildkraut Department of Community and Family Medicine, Duke University Medical Center, Durham, NC, USA; Cancer Prevention, Detection and Control Research Program, Duke Cancer Institute, Durham, NC, USA
Marjanka K Schmidt Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
Rita K Schmutzler Centre of Familial Breast and Ovarian Cancer, Department of Gynaecology and Obstetrics, University Hospital of Cologne, Cologne, Germany; Centre for Molecular Medicine Cologne (CMMC), University Hospital of Cologne, Cologne, Germany
Andreas Schneeweiss Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany
Minouk J Schoemaker Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, Surrey, UK
Michael G Schrauder University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany
Fredrick Schumacher Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
Ira Schwaab Institut für Humangenetik Wiesbaden, Wiesbaden, Germany
Giulietta Scuvera Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori (INT), Milan, Italy
Thomas A Sellers Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
Gianluca Severi Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, VIC, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia
Caroline M Seynaeve Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
Mitul Shah Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK
Martha Shrubsole Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA
Nadeem Siddiqui Department of Gynecological Oncology, Glasgow Royal Infirmary, Glasgow, UK
Weiva Sieh Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA, USA
Jacques Simard Centre Hospitalier Universitaire de Québec Research Center, Laval University, Quebec, Canada
Christian F Singer Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
Olga M Sinilnikova INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France; Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon, Centre Léon Bérard, Lyon, France
Dominiek Smeets Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Belgium; Vesalius Research Center (VRC), VIB, Leuven, Belgium
Christof Sohn Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany
Maria Soller Department of Clinical Genetics, University and Regional Laboratories, Lund University Hospital, Lund, Sweden
Honglin Song Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK
Penny Soucy Centre Hospitalier Universitaire de Québec Research Center, Laval University, Quebec, Canada
Melissa C Southey Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Melbourne, Australia
Christa Stegmaier Saarland Cancer Registry, Saarbrücken, Germany
Dominique Stoppa-Lyonnet Institut Curie, Department of Tumour Biology, Paris, France; Institut Curie, INSERM U830, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, France
Lara Sucheston Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA
Anthony Swerdlow Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, Surrey, UK; Division of Breast Cancer Research, The Institute of Cancer Research, Sutton, Surrey, UK
Ingvild L Tangen Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway; Department of Clinical Science, University of Bergen, Bergen, Norway
Muy-Kheng Tea Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
Manuel R Teixeira Department of Genetics, Portuguese Oncology Institute, Porto, Portugal; Biomedical Sciences Institute (ICBAS), Porto University, Porto, Portugal
Kathryn L Terry Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, MA, USA; Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA; Harvard Medical School, Boston, MA, USA
Mary Beth Terry Department of Epidemiology, Columbia University, New York, NY, USA
Mads Thomassen Department of Clinical Genetics, Odense University Hospital, Odense, Denmark
Pamela J Thompson Samuel Oschin Comprehensive Cancer Institute, Cedars Sinai Medical Center, Los Angeles, CA, USA
Laima Tihomirova Latvian Biomedical Research and Study Centre, Riga, Latvia
Marc Tischkowitz Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada
Amanda Ewart Toland Divison of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA
Rob A E M Tollenaar Department of Surgical Oncology, Leiden University Medical Center, Leiden, The Netherlands
Ian Tomlinson Welcome Trust Centre for Human Genetics, University of Oxford, UK; Oxford Biomedical Research Centre, University of Oxford, UK
Diana Torres Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany; Institute of Human Genetics, Pontificia Universidad Javeriana, Bogota, Colombia
Thérèse Truong INSERM U1018, CESP (Center for Research in Epidemiology and Population Health), Environmental Epidemiology of Cancer, Villejuif, France; University Paris-Sud, UMRS 1018, Villejuif, France
Helen Tsimiklis Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Melbourne, Australia
Nadine Tung Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA
Shelley S Tworoger Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA; Channing Division of Network Medicine, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA
Jonathan P Tyrer Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK
Celine M Vachon Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA
Laura J Van 't Veer Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
Anne M van Altena Department of Gynecology, Radboud University Medical Centre, Nijmegen, The Netherlands
C J Van Asperen Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands
David van den Berg Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
Ans M W van den Ouweland Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands
Helena C van Doorn Department of Gynecology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
Els Van Nieuwenhuysen Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven, Belgium; Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium
Elizabeth J van Rensburg Department of Genetics, University of Pretoria, Pretoria, South Africa
Ignace Vergote Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven, Belgium; Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium
Senno Verhoef Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
Robert A Vierkant Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA
Joseph Vijai Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Allison F Vitonis Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA
Anna von Wachenfeldt Department of Oncology, Karolinska University Hospital, Stockholm, Sweden
Christine Walsh Women's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA
Qin Wang Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Shan Wang-Gohrke Department of Obstetrics and Gynecology, University of Ulm, Ulm, Germany
Barbara Wappenschmidt Centre of Familial Breast and Ovarian Cancer, Department of Gynaecology and Obstetrics, University Hospital of Cologne, Cologne, Germany; Centre for Molecular Medicine Cologne (CMMC), University Hospital of Cologne, Cologne, Germany
Maren Weischer Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark; Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark
Jeffrey N Weitzel Clinical Cancer Genetics, City of Hope, Duarte, CA, USA
Caroline Weltens Multidisciplinary Breast Center, University Hospital Leuven, University of Leuven, Belgium
Nicolas Wentzensen Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
Alice S Whittemore Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA, USA
Lynne R Wilkens Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA
Robert Winqvist Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Genetics, University of Oulu, Oulu University Hospital, Oulu, Finland; Biocenter Oulu, University of Oulu, Oulu, Finland
Anna H Wu Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
Xifeng Wu Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Hannah P Yang Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
Daniela Zaffaroni Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori (INT), Milan, Italy
M Pilar Zamora Servicio de Oncología Médica, Hospital Universitario La Paz, Madrid, Spain
Wei Zheng Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA
Argyrios Ziogas Department of Epidemiology, Center for Cancer Genetics Research and Prevention, School of Medicine, University of California Irvine, Irvine, CA, USA
Georgia Chenevix-Trench Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia
Paul D P Pharoah Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK
Matti A Rookus Division of Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
Maartje J Hooning Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
Ellen L Goode Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA

Collapse

Mulrane L, McGee SF, Gallagher WM, O'Connor DP. miRNA dysregulation in breast cancer. Cancer Res 2013;73:6554-62. [PMID: 24204025 DOI: 10.1158/0008-5472.can-13-1841] [Citation(s) in RCA: 193] [Impact Index Per Article: 17.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]